title: Informing future cartilage repair strategies: a comparative study of three different human cell types for cartilage tissue engineering.
abstract: A major clinical need exists for cartilage repair and regeneration. Despite many different strategies having been pursued, the identification of an optimised cell type and of pre-treatment conditions remains a challenge. This study compares the cartilage-like tissue generated by human bone marrow stromal cells (HBMSCs) and human neonatal and adult chondrocytes cultured on three-dimensional (3D) scaffolds under various conditions in vitro and in vivo with the aim of informing future cartilage repair strategies based upon tissue-engineering approaches. After 3 weeks in vitro culture, all three cell types showed cartilage-like tissue formation on 3D poly (lactide-co-glycolide) acid scaffolds only when cultured in chondrogenic medium. After 6 weeks of chondro-induction, neonatal chondrocyte constructs revealed the most cartilage-like tissue formation with a prominent superficial zone-like layer, a middle zone-like structure and the thinnest fibrous capsule. HBMSC constructs had the thickest fibrous capsule formation. Under basal culture conditions, neonatal articular chondrocytes failed to form any tissue, whereas HBMSCs and adult chondrocytes showed thick fibrous capsule formation at 6 weeks. After in vivo implantation, all groups generated more compact tissues compared with in vitro constructs. Pre-culturing in chondrogenic media for 1 week before implantation reduced fibrous tissue formation in all cell constructs at week 3. After 6 weeks, only the adult chondrocyte group pre-cultured in chondrogenic media was able to maintain a more chondrogenic/less fibrocartilaginous phenotype. Thus, pre-culture under chondrogenic conditions is required to maintain a long-term chondrogenic phenotype, with adult chondrocytes being a more promising cell source than HBMSCs for articular cartilage tissue engineering.
authors.affiliation: Biomaterials and Tissue Engineering Group, Leeds Dental Institute, University of Leeds, Leeds, LS2 9LU, UK.
authors.forename: Sushmita
authors.initials: S
authors.lastname: Saha
authors.forename: Jennifer
authors.initials: J
authors.lastname: Kirkham
authors.forename: David
authors.initials: D
authors.lastname: Wood
authors.forename: Stephen
authors.initials: S
authors.lastname: Curran
authors.forename: Xuebin B
authors.initials: XB
authors.lastname: Yang
mesh_terms: D000328:Adult; D053674:Aggrecans / Q000378:metabolism; D000423:Alcian Blue / Q000378:metabolism; D002356:Cartilage / Q000502:physiology*; D002448:Cell Adhesion; D002465:Cell Movement; D002478:Cells, Cultured; D019902:Chondrocytes / Q000166:cytology*; D006801:Humans; D007150:Immunohistochemistry; D007231:Infant, Newborn; D059630:Mesenchymal Stem Cells / Q000166:cytology*; D018613:Microscopy, Confocal; D055758:SOX9 Transcription Factor / Q000378:metabolism; D013194:Staining and Labeling; D023822:Tissue Engineering / Q000379:methods*; D054457:Tissue Scaffolds / Q000737:chemistry; D014945:Wound Healing
chemical_list: D053674:Aggrecans; D055758:SOX9 Transcription Factor; C527932:SOX9 protein, human; D000423:Alcian Blue